[Edema as a measure for severity of chronic venous insufficiency and efficacy of its treatment]
- PMID: 19791434
[Edema as a measure for severity of chronic venous insufficiency and efficacy of its treatment]
Abstract
The author characterizes the edema as an important quantitative objective measure of severity for chronic venous diseases in both early and advanced stages. The problems of edema assessment methods and the importance of its management in clinical practice are discussed. The results of studies on the use of micronized purified flavonoid fraction (MPFF, Detralex) for edema syndrome coping are presented.
Similar articles
-
Controlled studies of Daflon 500 mg in chronic venous insufficiency.Angiology. 1994 Jun;45(6 Pt 2):549-53. Angiology. 1994. PMID: 8203786 Clinical Trial.
-
[The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].Ter Arkh. 1996;68(10):80-1. Ter Arkh. 1996. PMID: 9026954 Clinical Trial. Russian.
-
[Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder].Vnitr Lek. 2015 Sep;61(9):807-14. Vnitr Lek. 2015. PMID: 26465280 Review. Czech.
-
[Certain aspects of pathogenesis of hemorheological and trophic disturbances and their pharmacological correction in patients with chronic venous insufficiency].Vestn Khir Im I I Grek. 2008;167(2):39-43. Vestn Khir Im I I Grek. 2008. PMID: 18522184 Russian.
-
Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence.Vasc Health Risk Manag. 2021 Sep 16;17:591-600. doi: 10.2147/VHRM.S324112. eCollection 2021. Vasc Health Risk Manag. 2021. PMID: 34556990 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical